NIH Director Page NIH Health Information Page NIH Impact NIH Fact Sheets NIH Social Media and Outreach
EurekAlert! - National Institutes of Health  
LINKS

Resources

 

NIH Main

 

NIH Research News

 

Funded News

 
  For News & Research
  NIH Videos
  eColumn: NIH Research Matters
  NIH News in Health
  NIH Fact Sheets
 
  Additional Resources
  NIH Home Page
 

About NIH

  NIH Health Information
  Pub Med
  MedlinePlus
  Clinical trials.gov
  More News and Events Sources
  NIH News and Events, Special Interest
 
  RSS Feed RSS Feed
  Back to EurekAlert!
 

 


Department of Health and Human Services

News from the National Institutes of Health

NIH Research News


Key: Meeting M      Journal J      Funder F

Showing releases 76-87 out of 87.

<< < 1 | 2 | 3 | 4

Public Release: 29-Dec-2014
Journal of Allergy and Clinical Immunology
Estrogen worsens allergic reactions in mice
Estradiol, a type of estrogen, enhances the levels and activity in mice of an enzyme that drives life-threatening allergic reactions, according to NIAID researchers. The study results may help explain why women frequently experience more severe allergic reactions compared to men. Furthermore, the results reaffirm the importance of accounting for gender in the design of animal experiments.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Linda Huynh
niaidnews@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 23-Dec-2014
The Lancet
Scientists report on trial of early-generation Ebola, Marburg vaccine candidates
esults of an early-stage clinical trial of two experimental vaccines against Ebola and Marburg viruses -- the first to be completed in an African country -- showed that they were safe and induced immune responses in healthy Ugandan adult volunteers.
NIH/National Institute of Allergy and Infectious Diseases

Contact: NIAID Office of Communications
niaidnews@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 17-Dec-2014
JAMA Psychiatry
Despite risks, benzodiazepine use highest in older people
Prescription use of benzodiazepines -- a widely used class of sedative and anti-anxiety medications -- increases steadily with age, despite the known risks for older people, according to a comprehensive analysis of benzodiazepine prescribing in the United States. Given existing guidelines cautioning health providers about benzodiazepine use among older adults, findings from the National Institutes of Health-funded study raise questions about why so many prescriptions -- many for long-term use -- are being written for this age group.
NIH/National Institute of Mental Health, New York State Psychiatric Institute

Contact: Charlotte Armstrong
nimhpress@mail.nih.gov
301-443-4536
NIH/National Institute of Mental Health

Public Release: 16-Dec-2014
Teen prescription opioid abuse, cigarette, and alcohol use trends down
Use of cigarettes, alcohol, and abuse of prescription pain relievers among teens has declined since 2013 while marijuana use rates were stable, according to the 2014 Monitoring the Future (survey, released today by the National Institute on Drug Abuse. However, use of e-cigarettes, measured in the report for the first time, is high.
NIH/National Institute on Drug Abuse

Contact: NIDA Press Office
media@nida.nih.gov
301-443-6245
NIH/National Institute on Drug Abuse

Public Release: 8-Dec-2014
NIH initiates 'Centers Without Walls' to study sudden unexpected death in epilepsy
Nine groups of scientists will receive funding totaling $5.9 million in 2014 to work together on increasing the understanding of sudden unexpected death in epilepsy, the leading cause of death from epilepsy. The consortium becomes the second Center Without Walls, an initiative to speed the pace of research on difficult problems in epilepsy by promoting collaborative research. The National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health, funds this initiative.
NIH/National Institute of Neurological Disorders and Stroke

Contact: Barbara McMakin
nindspressteam@ninds.nih.gov
NIH/National Institute of Neurological Disorders and Stroke

Public Release: 4-Dec-2014
Science Translational Medicine
Imaging techniques reliably predict treatment outcomes for TB patients
Two medical imaging techniques, called positron emission tomography and computed tomography, could be used in combination as a biomarker to predict the effectiveness of antibiotic drug regimens being tested to treat tuberculosis patients, according to researchers at NIAID, part of NIH. With multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis on the rise worldwide, new biomarkers are needed to determine whether a particular TB drug regimen is effective.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Emily Mullin
emily.mullin@nih.gov
310-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 4-Dec-2014
American Journal of Psychiatry
Medications for patients with first episode psychosis may not meet guidelines
Many patients with first-episode psychosis receive medications that do not comply with recommended guidelines for first-episode treatment, researchers have found. Current guidelines emphasize low doses of antipsychotic drugs and strategies for minimizing the side effects that might contribute to patients stopping their medication. A NIH-funded study finds that almost 40 percent of people with first-episode psychosis in community mental health clinics across the country might benefit from medication treatment changes.
National Institutes of Health, NIH/National Institute of Mental Health

Contact: Michaelle Scanlon
NIMHpress@mail.nih.gov
301-443-4536
NIH/National Institute of Mental Health

Public Release: 3-Dec-2014
New England Journal of Medicine
NIH researchers link chromosome region to duplication of gene on X chromosome appears to cause excessive growth
Researchers at the National Institutes of Health have found a duplication of a short stretch of the X chromosome in some people with a rare disorder that causes excessive childhood growth. They believe that a single gene within the region likely has a large influence on how much children grow. The research comes from a lab at the National Institutes of Health's Eunice Kennedy Shriver National Institute of Child Health and Human Development, which seeks to understand growth.
National Institutes of Health

Contact: Robert Bock or Meredith Daly
dalym@mail.nih.gov
301-496-5133
NIH/Eunice Kennedy Shriver National Institute of Child Health and Human Development

Public Release: 3-Dec-2014
Nature
Barrier-breaking drug may lead to spinal cord injury treatments
Injections of a new drug may partially relieve paralyzing spinal cord injuries, based on indications from a study in rats, which was partly funded by the National Institutes of Health
NIH/National Institute of Neurological Disorders and Stroke, Case Western Reserve University Council to Advance Human Health, Mrs. Suzanne Poon, Unite to Fight Paralysis, Brumagin Memorial Fund, Spinal Cord Injury Sucks, United Paralysis Foundation

Contact: Christopher Thomas
thomaschr@ninds.nih.gov
301-496-5751
NIH/National Institute of Neurological Disorders and Stroke

Public Release: 3-Dec-2014
Science Translational Medicine
NIH-led scientists describe new herpes treatment strategy
Scientists have developed a novel treatment approach for persistent viral infections such as herpes. Using animal models of herpes simplex virus infection, researchers show that blocking the activity of a host cell protein called LSD1 reduces herpes infection, shedding and recurrence.
NIH/National Institute of Allergy and Infectious Disease

Contact: Hillary Hoffman
hillary.hoffman@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 1-Dec-2014
PLOS ONE
Sophisticated HIV diagnostics adapted for remote areas
Diagnosing HIV and other infectious diseases presents unique challenges in remote locations that lack electric power, refrigeration, and appropriately trained health care staff. To address these issues, researchers funded by the National Institutes of Health have developed a low-cost, electricity-free device capable of detecting the DNA of infectious pathogens, including HIV-1.
NIH/National Institute of Biomedical Imaging and Bioengineering

Contact: Margot Kern
nibibpress@mail.nih.gov
301-496-3500
NIH/National Institute of Biomedical Imaging & Bioengineering

Public Release: 1-Dec-2014
Pediatrics
Nearly 55 percent of US infants sleep with potentially unsafe bedding
Nearly 55 percent of US infants are placed to sleep with bedding that increases the risk of sudden infant death syndrome, or SIDS, despite recommendations against the practice, report researchers at the National Institutes of Health, the Centers for Disease Control and Prevention, and other institutions.
National Institutes of Health

Contact: Robert Bock or Meredith Daly
bockr@mail.nih.gov
301-496-5133
NIH/Eunice Kennedy Shriver National Institute of Child Health and Human Development

Showing releases 76-87 out of 87.

<< < 1 | 2 | 3 | 4

     
   

HOME    DISCLAIMER    PRIVACY POLICY    CONTACT US
Copyright ©2015 by AAAS, the science society.